Skip to main content
Veterinary Medicines

Poulvac IB Primer Oral solution or spray solution after reconstitution of the freeze-dried vaccine in water

Authorised
  • Avian infectious bronchitis virus, strain D274, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live

Product identification

Medicine name:
Poulvac IB Primer Oral solution or spray solution after reconstitution of the freeze-dried vaccine in water
Poulvac IB Primer Lyofilisaat voor vernevelsuspensie/oogdruppels, suspensie/gebruik in drinkwater
Poulvac IB Primer Lyophilisat pour suspension pour inhalation par nébuliseur/collyre en suspension/administration dans l'eau de boisson
Poulvac IB Primer Lyophilisat zur Herstellung einer Suspension für einen Vernebler/zur Herstellung einer Augentropfensuspension/zum Eingeben über das Trinkwasser
Active substance:
  • Avian infectious bronchitis virus, strain D274, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken
Route of administration:
  • Nebulisation use
  • In drinking water use
  • Oculonasal use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, strain D274, Live
    1000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    1000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • In drinking water use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • (ID4) 10000 Dose: Box (board) with 10 Bottle each with 1000 Dose, closed with (Aluminium) and (chlorobutylrubber`)
  • (ID6) 50000 Dose: Box (board) with 10 Bottle each with 5000 Dose, closed with (Aluminium) and (chlorobutylrubber`)
  • (ID5) 25000 Dose: Box (board) with 10 Bottle each with 2500 Dose, closed with (Aluminium) and (chlorobutylrubber`)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V589573
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0259/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Netherlands
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Sweden

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 28/08/2025
French (PDF)
Published on: 28/08/2025
German (PDF)
Published on: 28/08/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 28/08/2025
French (PDF)
Published on: 28/08/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 28/08/2025
French (PDF)
Published on: 28/08/2025
German (PDF)
Published on: 28/08/2025

Combined File of all Documents

English (PDF)
Published on: 14/11/2025
Download